CareDx (CDNA) Cost of Revenue (2013 - 2026)

CareDx has reported Cost of Revenue for 14 years, with the latest figure at $15.9 million in Q2 2026.

• Quarterly Cost of Revenue rose 3.32% year-over-year to $15.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $64.5 million (up 10.91% YoY) and the FY2025 annual result came in at $62.0 million, up 11.57% from the prior year.
• Cost of Revenue declined to $15.9 million in Q2 2026 per CDNA's latest filing, from $17.1 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $18.7 million in Q4 2022 and troughed at $13.2 million in Q3 2023.
• A 5-year average of $15.6 million and a median of $15.3 million in 2023 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2023 and 2025: Cost of Revenue dropped 26.01% in 2023, then grew 18.26% in 2025.
• Over 5 years, Cost of Revenue stood at $18.7 million in 2022, then decreased by 26.01% to $13.8 million in 2023, then advanced by 3.04% to $14.2 million in 2024, then advanced by 18.26% to $16.8 million in 2025, then decreased by 5.37% to $15.9 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $15.9 million, $17.1 million, and $16.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.